7:30 am Registration and Breakfast
8:00 Opening Remarks
Lori Pickens, MHA, Senior Vice President and Executive Director, Smilow Cancer Hospital
8:15 Session One: The Changing Landscape of Hepatocellular
Carcinoma (HCC) Management—Between Reality and Predictions
Moderators: Mario Strazzabosco, MD, PhD
, Professor of Medicine; Clinical Program Leader, Liver Cancer Program; Deputy Director, Yale Liver Center
and Biomedical Imaging
Big Data: Artificial Intelligence Solutions for Decision Making
10:55 Session Two: The Patient With Early Stage Disease:What is the First Line Therapy?
Moderator: Nita Ahuja, MD, MBA
, Chair, Department of Surgery; William H. Carmalt Professor of Surgery
Medical Director, Adult Liver Transplant Center
1:00 pm Lunch
2:00 Session Three: The Patient With Intermediate Stage Disease: New Frontiers
Moderator: Sukru Emre, MD
, Professor of Surgery (Transplant) and of Pediatrics
Kevin Kim, MD
, Professor of Radiology and Biomedical Imaging; Professor of Medicine (Medical Oncology)
3:40 Session Four: The Patient with Advanced Stage Disease
Michael Nathanson, MD, PhD
, Gladys Phillips Crofoot Professor of Medicine (Digestive Diseases); Professor of Cell Biology; Director, Yale Liver Center
Andrew Putnam, MD
, Assistant Professor of Medicine; Smilow Cancer Hospital Palliative Care Program
4:40 Putting it all Together
The Yale School of Medicine designates this live activity for a maximum of 7.25 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Yale School of Medicine is accredited by the Accreditation Council for Continuing Medical Education
to provide continuing medical education for physicians.